Gilead Sciences (GILD) News Today $96.04 -2.00 (-2.04%) Closing price 02/7/2025 04:00 PM EasternExtended Trading$96.02 -0.02 (-0.02%) As of 02/7/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period These 2 Dividend Stocks Are Absolute Bargains Right NowFebruary 8 at 8:30 AM | fool.comGilead Sciences, Inc. (NASDAQ:GILD) Position Lessened by Conning Inc.Conning Inc. decreased its holdings in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 13.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 415,223 shares of the biopharmaceutical company's stock after selling 6February 8 at 6:24 AM | marketbeat.comNatWest Group plc Purchases Shares of 73,702 Gilead Sciences, Inc. (NASDAQ:GILD)NatWest Group plc acquired a new position in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 73,702 shares of the biopharmaceutical company's stock, valued at apFebruary 8 at 5:47 AM | marketbeat.comLecap Asset Management Ltd. Lowers Position in Gilead Sciences, Inc. (NASDAQ:GILD)Lecap Asset Management Ltd. trimmed its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 23.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 10,020 shares of the bFebruary 8 at 5:25 AM | marketbeat.comFinancial Advocates Investment Management Sells 6,372 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)Financial Advocates Investment Management lessened its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 42.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 8,73February 8 at 4:30 AM | marketbeat.comTobam Sells 3,687 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)Tobam trimmed its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 28.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 9,275 shares of the biopharmaceutical company's stock afterFebruary 7 at 8:16 AM | marketbeat.comSumitomo Mitsui DS Asset Management Company Ltd Increases Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)Sumitomo Mitsui DS Asset Management Company Ltd increased its stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 4.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 159,693 shares of the bioFebruary 7 at 7:15 AM | marketbeat.comSumitomo Mitsui Trust Group Inc. Boosts Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)Sumitomo Mitsui Trust Group Inc. grew its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 0.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,034,060 shares of the biopharmaceuticalFebruary 7 at 7:15 AM | marketbeat.comRNC Capital Management LLC Sells 190,748 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)RNC Capital Management LLC decreased its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 29.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 458,670 shares ofFebruary 7 at 6:56 AM | marketbeat.comLeo Wealth LLC Has $1.08 Million Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)Leo Wealth LLC trimmed its holdings in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 58.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,705 shares of the biopharmaceuticalFebruary 7 at 6:33 AM | marketbeat.comEtesian Wealth Advisors Inc. Sells 2,860 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)Etesian Wealth Advisors Inc. lessened its stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 18.4% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 12,708 shares of the biopharmaceutical company's stock after sellinFebruary 6 at 8:14 AM | marketbeat.comState of Alaska Department of Revenue Has $16.66 Million Stake in Gilead Sciences, Inc. (NASDAQ:GILD)State of Alaska Department of Revenue trimmed its stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 12.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 180,407 shares of the biopharmaceutical company's sFebruary 6 at 8:02 AM | marketbeat.comIs Harmony Biosciences Holdings Inc. (HRMY) a Biotech Stock to Consider?February 6 at 7:03 AM | stocknews.comVision Capital Management Inc. Decreases Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)Vision Capital Management Inc. reduced its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 43.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,119 shares of the biopharmacFebruary 6 at 7:01 AM | marketbeat.comTrilogy Capital Inc. Reduces Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)Trilogy Capital Inc. lowered its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 9.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 37,307 shares of the biopharmaceutical comFebruary 6 at 6:49 AM | marketbeat.comPrivate Management Group Inc. Trims Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)Private Management Group Inc. lessened its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 49.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 211,383 shares of theFebruary 6 at 5:48 AM | marketbeat.comConfluence Wealth Services Inc. Sells 8,871 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)Confluence Wealth Services Inc. trimmed its stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 61.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 5,464 shares of the biopharmaceutical companFebruary 6 at 5:29 AM | marketbeat.comStratos Wealth Partners LTD. Decreases Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)Stratos Wealth Partners LTD. lowered its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 26.6% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 84,014 shares of the biopharmaceutical company's stockFebruary 6 at 4:55 AM | marketbeat.comSargent Investment Group LLC Makes New Investment in Gilead Sciences, Inc. (NASDAQ:GILD)Sargent Investment Group LLC bought a new position in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 5,054 shares of the biopharmaceutical company's stock, valued at approxFebruary 6 at 4:25 AM | marketbeat.comGilead Sciences, Inc. (NASDAQ:GILD) Holdings Decreased by U.S. Capital Wealth Advisors LLCU.S. Capital Wealth Advisors LLC lessened its stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 90.6% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 6,705 shares of the biopharmaceutical companyFebruary 6 at 3:41 AM | marketbeat.comAnalysts Set Gilead Sciences, Inc. (NASDAQ:GILD) PT at $98.39February 6 at 1:45 AM | americanbankingnews.comGilead Sciences (NASDAQ:GILD) Hits New 12-Month High - Time to Buy?Gilead Sciences (NASDAQ:GILD) Sets New 12-Month High - Should You Buy?February 5 at 5:06 PM | marketbeat.comMeritage Portfolio Management Sells 3,727 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)Meritage Portfolio Management lowered its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 6.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 54,876 shares of the biopharmaceuticFebruary 5 at 8:54 AM | marketbeat.comTectonic Advisors LLC Increases Position in Gilead Sciences, Inc. (NASDAQ:GILD)Tectonic Advisors LLC grew its position in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 7.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 81,286 shares of the biopharmaceutical company's stFebruary 5 at 8:35 AM | marketbeat.comMoney Concepts Capital Corp Has $8.36 Million Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)Money Concepts Capital Corp reduced its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 4.0% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 90,538 shares of the biopharmaceutical company's stoFebruary 5 at 8:22 AM | marketbeat.comMirae Asset Global Investments Co. Ltd. Has $40.69 Million Stake in Gilead Sciences, Inc. (NASDAQ:GILD)Mirae Asset Global Investments Co. Ltd. raised its stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 8.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 434,165 shares of the biopharmaceutical company's stFebruary 5 at 7:58 AM | marketbeat.comGilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Yousif Capital Management LLCYousif Capital Management LLC trimmed its holdings in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 2.0% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 150,974 shares of the biopharmaceutical comFebruary 5 at 6:35 AM | marketbeat.comRetirement Systems of Alabama Boosts Stake in Gilead Sciences, Inc. (NASDAQ:GILD)Retirement Systems of Alabama increased its position in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 31.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 998,307 shares of the biopharmaceutical company's stock afFebruary 5 at 6:33 AM | marketbeat.comARGA Investment Management LP Sells 683,916 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)ARGA Investment Management LP cut its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 79.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 180,870 shares of the biopharmaceutical coFebruary 5 at 5:47 AM | marketbeat.comOptas LLC Makes New Investment in Gilead Sciences, Inc. (NASDAQ:GILD)Optas LLC acquired a new stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor acquired 2,597 shares of the biopharmaceutical company's stock, valued at approximately $240,000. A number of othFebruary 5 at 4:36 AM | marketbeat.comRoyal Bank of Canada Reaffirms Sector Perform Rating for Gilead Sciences (NASDAQ:GILD)February 5 at 2:58 AM | americanbankingnews.comGilead Sciences, Inc. (NASDAQ:GILD) Stock Position Raised by E. Ohman J or Asset Management ABE. Ohman J or Asset Management AB lifted its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 14.0% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 57,590 shares of the biopharmaceutical company'February 4, 2025 | marketbeat.comCullinan Associates Inc. Trims Position in Gilead Sciences, Inc. (NASDAQ:GILD)Cullinan Associates Inc. reduced its position in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 85.0% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 15,141 shares of the biopharmaceutical company's stock after selling 85,844 shares during the period. CullFebruary 4, 2025 | marketbeat.comColumbus Macro LLC Has $2.32 Million Position in Gilead Sciences, Inc. (NASDAQ:GILD)Columbus Macro LLC boosted its stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 55.9% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 25,103 shares of the biopharmaceutical companFebruary 4, 2025 | marketbeat.comabrdn plc Cuts Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)abrdn plc lowered its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 6.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,767,955 shares of the biopharmaceutical company's stocFebruary 4, 2025 | marketbeat.comGilead Sciences (GILD) Projected to Post Quarterly Earnings on TuesdayGilead Sciences (NASDAQ:GILD) will be releasing earnings after the market closes on Tuesday, February 11, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=651977)February 4, 2025 | marketbeat.comJennison Associates LLC Buys Shares of 943,628 Gilead Sciences, Inc. (NASDAQ:GILD)Jennison Associates LLC bought a new position in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 943,628 shares of the biopharmaceutical company's stock,February 4, 2025 | marketbeat.comGilead Sciences, Inc. (NASDAQ:GILD) CFO Andrew D. Dickinson Sells 142,180 SharesGilead Sciences, Inc. (NASDAQ:GILD - Get Free Report) CFO Andrew D. Dickinson sold 142,180 shares of the stock in a transaction on Friday, January 31st. The shares were sold at an average price of $97.22, for a total transaction of $13,822,739.60. Following the completion of the sale, the chief financial officer now owns 129,873 shares of the company's stock, valued at approximately $12,626,253.06. This represents a 52.26 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.February 3, 2025 | marketbeat.comGilead: Strong Sales Growth Remains With Veklury And BeyondFebruary 3, 2025 | seekingalpha.comGilead call volume above normal and directionally bullishFebruary 3, 2025 | markets.businessinsider.comGilead Sciences (NASDAQ:GILD) Sets New 12-Month High - Here's WhyGilead Sciences (NASDAQ:GILD) Sets New 12-Month High - What's Next?February 3, 2025 | marketbeat.comGilead Sciences Sees Unusually Large Options Volume (NASDAQ:GILD)Gilead Sciences, Inc. (NASDAQ:GILD - Get Free Report) saw some unusual options trading activity on Monday. Stock traders bought 14,742 call options on the stock. This represents an increase of approximately 45% compared to the average volume of 10,166 call options.February 3, 2025 | marketbeat.comGilead Sciences' (GILD) Sector Perform Rating Reaffirmed at Royal Bank of CanadaRoyal Bank of Canada reissued a "sector perform" rating and issued a $84.00 price target on shares of Gilead Sciences in a report on Monday.February 3, 2025 | marketbeat.comGilead Sciences Stock: Is Wall Street Bullish or Bearish?February 3, 2025 | msn.comGilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Lazari Capital Management Inc.Lazari Capital Management Inc. cut its stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 68.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,463 shares of the biopharmaceutical company's stockFebruary 3, 2025 | marketbeat.comGilead Sciences, Inc. (NASDAQ:GILD) Given Consensus Recommendation of "Moderate Buy" by AnalystsShares of Gilead Sciences, Inc. (NASDAQ:GILD - Get Free Report) have received an average rating of "Moderate Buy" from the twenty-seven research firms that are covering the company, MarketBeat reports. Eleven equities research analysts have rated the stock with a hold recommendation, thirteen haveFebruary 3, 2025 | marketbeat.comValley National Advisers Inc. Sells 9,062 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)Valley National Advisers Inc. decreased its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 19.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 38,093 shares of the biopharmaceutical cFebruary 2, 2025 | marketbeat.comGilead Sciences, Inc. (NASDAQ:GILD) Shares Bought by McAdam LLCMcAdam LLC increased its position in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 16.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 25,372 shares of the biopharmaceutical company's stockFebruary 2, 2025 | marketbeat.comClear Creek Financial Management LLC Acquires Shares of 12,702 Gilead Sciences, Inc. (NASDAQ:GILD)Clear Creek Financial Management LLC bought a new position in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm bought 12,702 shares of the biopharmaceutical company's stock, valued atFebruary 2, 2025 | marketbeat.comMediolanum International Funds Ltd Has $5.32 Million Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)Mediolanum International Funds Ltd decreased its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 6.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 57,910 shaFebruary 2, 2025 | marketbeat.com Get Gilead Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GILD and its competitors with MarketBeat's FREE daily newsletter. Email Address GILD Media Mentions By Week GILD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GILD News Sentiment▼1.300.59▲Average Medical News Sentiment GILD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GILD Articles This Week▼5321▲GILD Articles Average Week Get Gilead Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GILD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AMGN News Today VRTX News Today REGN News Today ALNY News Today BIIB News Today UTHR News Today NBIX News Today INCY News Today BMRN News Today EXAS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GILD) was last updated on 2/8/2025 by MarketBeat.com Staff From Our PartnersA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Crypto Is Set to Explode in JanuaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredThe Secret Winner in Trump’s AI RevolutionTrump just announced a $500 billion plan to revolutionize artificial intelligence. He's calling it The Star...Behind the Markets | SponsoredCould 1 of these 5 “America First” stocks 26x from here?Tim Bohen says these 5 tiny “America First” stocks are next up in 2025. They’re trading for less than $2 ri...Timothy Sykes | SponsoredElon Musk’s secret rendezvous with Jensen HuangElon Musk is the world's richest person, and it's not even close. Now he's got the ear of President Trump, ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gilead Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gilead Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free Gild Stock Alerts